CRISPR Therapeutics (CRSP) PT Raised to $80 at H.C. Wainwright
Tweet Send to a Friend
(Updated - August 7, 2025 7:18 AM EDT)
H.C. Wainwright analyst Mitchell Kapoor raised the price target on CRISPR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Mitchell Kapoor raised the price target on CRISPR ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
